Diabetes and risk of pancreatic cancer: A pooled analysis from the pancreatic cancer cohort consortium

Cancer Causes and Control

Volumn 24, Issue 1, 2013, Pages 13-25

  Elena, Joanne W ^a   Steplowski, Emily ^b   Yu, Kai ^a   Hartge, Patricia ^a   Tobias, Geoffrey S ^a   Brotzman, Michelle J ^c   Chanock, Stephen J ^a   Stolzenberg Solomon, Rachael Z ^a   Arslan, Alan A ^d,e   Bueno De Mesquita, H Bas ^f,g   Helzlsouer, Kathy ^h   Jacobs, Eric J ^k   Lacroix, Andrea ^l   Petersen, Gloria ^m   Zheng, Wei ⁿ   Albanes, Demetrius ^a   Allen, Naomi E ^o   Amundadottir, Laufey ^a   Bao, Ying ^p   Boeing, Heiner ^q   Boutron Ruault, Marie Christine ^r   Buring, Julie E ^p,s   Gaziano, J Michael ^p,t   Giovannucci, Edward L ^u   Duell, Eric J ^v   Hallmans, Göran ^w   Howard, Barbara V ^x   Hunter, David J ^u   Hutchinson, Amy ^a,y   Jacobs, Kevin B ^a   Kooperberg, Charles ^l   Kraft, Peter ^u   Mendelsohn, Julie B ^a   Michaud, Dominique S ^z,aa   Palli, Domenico ^ab   Phillips, Lawrence S ^ac,ad   Overvad, Kim ^ae   Patel, Alpa V ^k   Sansbury, Leah ^a,af   Shu, Xiao Ou ⁿ   Simon, Michael S ^ag   Slimani, Nadia ^ah   Trichopoulos, Dimitrios ^u,ai   Visvanathan, Kala ^i,j   Virtamo, Jarmo ^aj   Wolpin, Brian M ^p,ak   Zeleniuch Jacquotte, Anne ^d,e   Fuchs, Charles S ^p,ak   Hoover, Robert N ^a   Gross, Myron ^al   more..

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c WESTAT   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NEW YORK UNIVERSITY   (United States)

^f NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h MERCY MEDICAL CENTER   (United States)

ⁱ JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^j JOHNS HOPKINS UNIVERSITY   (United States)

^k AMERICAN CANCER SOCIETY   (United States)

^l USA   (United States)

^m MAYO CLINIC   (United States)

ⁿ VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^o UNIVERSITY OF OXFORD   (United Kingdom)

^p BRIGHAM AND WOMEN S HOSPITAL   (United States)

^q GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^r INSERM   (France)

^s HARVARD MEDICAL SCHOOL   (United States)

^t VETERANS AFFAIRS MEDICAL CENTER   (United States)

^u HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^v CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^w UMEÅ UNIVERSITY   (Sweden)

^x GEORGETOWN UNIVERSITY   (United States)

^y SAIC FREDERICK INC   (United States)

^z BROWN UNIVERSITY   (United States)

^aa IMPERIAL COLLEGE LONDON   (United Kingdom)

^ab CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^ac EMORY UNIVERSITY   (United States)

^ad ATLANTA VA MEDICAL CENTER   (United States)

^ae AARHUS UNIVERSITY   (Denmark)

^af GLAXOSMITHKLINE   (United States)

^ag WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ah INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ai BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^aj NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^ak DANA FARBER CANCER INSTITUTE   (United States)

^al UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

more..

Author keywords

Cohort consortium; Diabetes; Pancreatic cancer; Risk factor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SELF REPORT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RISK FACTORS;

EID: 84871770725     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0078-8     Document Type: Article

References (50)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics. CA Cancer J Clin 2012:6210-6229
2. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-108 (Pubitemid 40372904)
3. Raimondi S, Maisonneuve P, Lowenfels AB (2009) Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 6(12):699-708
4. Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P et al (2009) Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol 170(4):403-413
5. Jacobs EJ, Chanock SJ, Fuchs CS, LaCroix A, McWilliams RR, Steplowski E et al (2010) Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int J Cancer 127(6):1421-1428
6. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA et al (2009) Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 41(9):986-990
7. Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, Steplowski E et al (2010) Pancreatic cancer risk and ABO blood group alleles: results from the Pancreatic Cancer Cohort Consortium. Cancer Res 70(3):1015-1023
8. Wolpin BM, Kraft P, Xu M, Steplowski E, Olsson ML, Arslan AA et al (2010) Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the Pancreatic Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 19(12):3140-3149
9. Arslan AA, Helzlsouer KJ, Kooperberg C, Shu X-O, Steplowski E, Bueno-de-Mesquita HB et al (2010) Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 170(9):791-802
10. Vrieling A, Bueno-de-Mesquita HB, Boshuizen HC, Michaud DS, Severinsen MT, Overvad K et al (2010) Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 126(10):2394-2403
11. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14(3):173-194
12. Bao B, Wang Z, Li Y, Kong D, Ali S, Banerjee S et al (2011) The complexities of obesity, diabetes, and the development and progression of pancreatic cancer. Biochim Biophys Acta 1885(2):135-146
13. Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M et al (2008) Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterol 134(1):95-101 (Pubitemid 350309328)
14. Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273(20):1605-1609
15. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92(11):2076-2083 (Pubitemid 40897433)
16. The ATBC Cancer Prevention Study Group (1994) The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4:1-10
17. Gallicchio L, Chang H, Christo D, Thuita L, Huang H, Strickland P et al (2008) Single nucleotide polymorphisms in inflammation-related genes and mortality in a community-based cohort in Washington County, Maryland. Am J Epidemiol 167:807-813 (Pubitemid 351451746)
18. Calle E, Rodriguez C, Jacobs E, Almon M, Chao A, McCullough M et al (2002) The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design and baseline characteristics. Cancer 94:2490-2501 (Pubitemid 34457132)
19. Riboli E, Hunt K, Slimani N, Ferrari P, Norat T, Fahey M et al (2002) European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113-1124 (Pubitemid 36313608)
20. Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE et al (2007) Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer. Cancer Res 67(16):7923-7928 (Pubitemid 47281389)
21. McWilliams RR, Bamlet WR, Cunningham JM, Goode EL, Andrade Md, Boardman LA et al (2008) Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 68(12):4928-4935
22. Zeleniuch-Jacquotte A, Gu Y, Shore RE, Koenig KL, Arslan AA, Kato I et al (2005) Postmenopausal levels of sex hormones and risk of breast carcinoma in situ: results of a prospective study. Int J Cancer 114(2):323-327 (Pubitemid 40194302)
23. Hayes RB, Sigurdson A, Moore L, Peters U, Huang W-Y, Pinsky P et al (2005) Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res 592(1-2):147-154 (Pubitemid 41714051)
24. Xu W-H, Zhang X-L, Gao Y-T, Xiang Y-B, Gao L-F, Zheng W et al (2007) Joint effect of cigarette smoking and alcohol consumption on mortality. Prev Med 45(4):313-319 (Pubitemid 47562528)
25. Zheng W, Chow W-H, Yang G, Jin F, Rothman N, Blair A et al (2005) The Shanghai Women's Health study: rationale, study design, and baseline characteristics. Am J Epidemiol 162(11):1123-1131 (Pubitemid 41746625)
26. Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, et al (2003) Implementation of the women's health initiative study design. Ann Epidemiol 13(9 Suppl 1):S5-S17 (Pubitemid 37324175)
27. Rexrode K, Lee I, Cook N, Hennekens C, Buring J (2000) Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 9(1):19-27 (Pubitemid 30148098)
28. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey J-N, Pisters PW et al (2007) Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 102(12):2696-2707 (Pubitemid 350179330)
29. Jamal MM, Yoon EJ, Vega KJ, Hashemzadeh M, Chang KJ (2009) Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol 15(42):5274-5278
30. Chodick G, Heymann AD, Rosenmann L, Green MS, Flash S, Porath A et al (2010) Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control 21(6):879-887
31. Li D, Abbruzzese J (2010) New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts. Clin Cancer Res 16(17):4313-4318
32. Batty G, Kivimaki M, Morrison D, Huxley R, Smith G, Clarke R et al (2009) Risk factors for pancreatic cancer mortality: extended follow-up of the original Whitehall Study. Cancer Epidemiol Biomarkers Prev 18(2):673-675
33. Hemminki K, Li X, Sundquist J, Sundquist K (2010) Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15(6):548-555
34. Ammon HPT (1997) Hyper- and hypoinsulinemia in type-2 diabetes: what may be wrong in the secretory mechanism of the B-cell. Exp Clin Endocrinol Diabetes 105(S02):43,7
35. Gapstur SM, Liu K, Gann PH, Dyer A (2000) Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283(19):2595-2596
36. Batty GD, Shipley MJ, Marmot M, Smith GD (2004) Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control 15(9):873-881 (Pubitemid 39663863)
37. Michaud DS, Wolpin B, Giovannucci E, Liu S, Cochrane B, Manson JE et al (2007) Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 16(10):2101-2109 (Pubitemid 47621187)
38. Stattin P, Björ O, Ferrari P, Lukanova A, Lenner P, Lindahl B et al (2007) Prospective study of hyperglycemia and cancer risk. Diabetes Care 30(3):561-567 (Pubitemid 46354334)
39. Grote V, Becker S, Kaaks R (2010) Diabetes mellitus type 2: an independent risk factor for cancer? Exp Clin Endocrinol Diabetes 118(1):4-8
40. Grote V, Rohrmann S, Nieters A, Dossus L, Tjønneland A, Halkjær J et al (2011) Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia 54(12):3037-3046
41. Stolzenberg-Solomon RZ, Graubard BI, Chari S, Limburg P, Taylor PR, Virtamo J et al (2005) Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294(22):2872-2878 (Pubitemid 41785868)
42. Li D, Yeung S-CJ, Hassan MM, Konopleva M, Abbruzzese JL (2009) Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterol 137(2):482-488
43. McFarland MS, Cripps R (2010) Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs. Pharmacotherapy 30(11):1159-1178
44. Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM, Chari ST (2008) Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterol 134(4):981-987 (Pubitemid 351451984)
45. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B et al (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467(7319):1114-1117
46. World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR) (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR
47. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML et al (2009) Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 301(24):2553-2562
48. Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE et al (2011) A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 129(7):1708-1717
49. Centers for Disease Control and Prevention (2011) National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. US Department of Health and Human Services, Centers for Disease Control and Prevention. Atlanta, GA
50. National Institute of Diabetes and Digestive and Kidney Diseases (2008) National Diabetes Statistics, 2007 fact sheet. National Institutes of Health, Bethesda, MD